INDEX OF SUBJECTS 



Adenocarcinoma, metastases from in 



radiation chimeras, 167-168 

 Adoptive immunization, 143-144, 

 386 

 and thymectomy, 392 

 Adoptive transfer, of spleen cells, in 

 treatment of runt disease, 360-365 

 Agammaglobulinaemia, 232, 233, 



280 

 Age, and parabiotic disease, 330-331 

 effect on immunologically incom- 

 petent cells, 202-203, 2 1 0-2 1 1 

 effect on results of thymectomy, 



398 

 effect on transplantation tolerance 

 and immunity, 138-162 

 "Allergic death", 383 

 Allergic encephalomyeHtis, 229, 233 

 Allergy, to bacteria, 137 

 Amethopterin, 



in runt disease, 352, 370-373, 376 



due to presensitized cells, 381 



4 - Amino - N^^ - methylpteroyl - 



glutamic acid, see Amethopterin 

 Amnion, iii 



Antibodies, effect on sensitizing anti- 

 gens, 6-7 

 synergistic action of, no, 217-218, 

 227-228, 231-232 

 Antibody formation, 211-212 

 after transfer, 235 

 and enhancement, 409, 410 

 effect of thymectomy, 3 84 

 in clonal selection theory, 201 

 in thymus, 403 

 mechanism of stimulus, 201 

 phases of, 201 

 transfer of, 232 

 "Antigen 3", 58, 62, 66, 70 



"Antigen 4", 36 



Antigen administration, intravenous 



route, 12, 14, 21, 129 



routes of, 20-21, 136-137 

 Antigenic strength, and clonal selec- 

 tion theory, 206, 207 



in runt disease, 343 



in skin grafts, 200 



in terms of ranting power, 196-200 



in tolerance, 210, 340 

 Antigen production, loss of, in 



tumour transplantation, 176, 180 

 Antigens, and structure, 45-46 



effect on antibodies, 6 



inactivation of, by connective 

 tissue, 115 



of mouse cells, 58 



sensitizing antibodies, 6-7 



transplantation, see Transplantation 

 antigens 

 Antisera, from tumour tissue, 292 

 Ascites, non-mahgnant production of, 



68 

 Ascitic cells, of sarcoma i, isoanti- 



genic Upoprotein from, 73-77 

 Ascitic fluid, 36 



analysis of, 52 



antigen extraction from, contami- 

 nation, 53-54 



effect of immunization on skin 

 grafts, 63 



enzymic degradation of, 3 8 



extraction of antigens from, 49-53 



H-2 antigens in, possible source of, 

 66-67 



H-2 antisera prepared from, 46 



H-2 specificity of, 48-49 



Bacteria, delayed allergy to, 137 



415 



